Metabolic SyndromeNCT06179810
Effect of Baduanjin Exercise on Metabolic Syndrome Patients
A study testing Baduanjin exercise in people with Metabolic Syndrome, run by Cairo University at 1 site in Egypt.
Trial summary
Pre/posttest randomized control trial design. In this study all patients will be randomly assigned into two groups (30 in each group) : Group A will do baduanjin exercise in addition to traditional medical treatment. Group B will take traditional medical treatment only. Read more about this study
- Who is it for?
- Ages 60 to 75 yearsHealthy volunteers can take part
- Conditions the study is for
- Metabolic Syndrome
- What is being tested?
- Baduanjin exercise
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteEgypt
- Study dates
- 15 May 2023to 15 Dec 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 to 75 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- metabolic syndrome patients
Who cannot join
- patients with Respiratory diseases
- patients with pacemaker patients
- patients with Neurological diseases
- patients with orthopedic diseases
Trial locations and contacts
1 site in 1 country.
Egypt1 site, 1 recruiting
- Recruiting
Ahmed Mohamed Abdelrahman Eldeeb
Cairo, Qaliop Elbalad
Ahmed Mohamed Eldeeb, Master, 01153278847, eldeebahmed2018@gmail.com
About this study
Official title: Effect of Baduanjin Exercise on Quality of Life in Patients With Metabolic Syndrome
Pre/posttest randomized control trial design.
In this study all patients will be randomly assigned into two groups (30 in each group) :
- Group A will do baduanjin exercise in addition to traditional medical treatment.
- Group B will take traditional medical treatment only.
- Conditions
- Metabolic Syndrome
- Being tested
- Baduanjin exercise
- Medical subject headings
- Metabolic Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Baduanjin exerciseOther
Baduanjin exercise
| Study group | Role | What they receive |
|---|---|---|
| Baduanjin exercise in addition to medical treatment | Experimental | 30 patients with metabolic syndrome do baduanjin exercise in addition to traditional medical treatment Receives: Other: Baduanjin exercise |
| Traditional medical treatment | Experimental | 30 patients with metabolic syndrome taking traditional medical treatment Receives: Other: Baduanjin exercise |
What is being measured
The primary outcome is the main question the study is designed to answer.
Fasting glucose level
Pre/post fasting glucose level in blood
Measured: 3 months
Lipids profile
Pre/post HDL \& lDL levels in blood
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Dec 2023
- Study start15 May 2023
- Primary completion15 Dec 2023 (estimated)
- Study completion15 Dec 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Metabolic SyndromeStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Pre/posttest randomized control trial
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ahmed eldeeb, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06179810
- Sponsor's protocol ID
- P. T. REC/012/004558
- Status last verified
- Dec 2023
- First submitted
- 12 Dec 2023
- Last updated
- 22 Dec 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Dec 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Baduanjin Exercise on Quality of Life in Patients With Metabolic Syndrome
- ClinicalTrials.gov ID
- NCT06179810
- Acronym / sponsor ID
- P. T. REC/012/004558
- Conditions
- Metabolic Syndrome
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 15 May 2023 (actual)
- Primary completion
- 15 Dec 2023 (estimated)
- Study completion
- 15 Dec 2023 (estimated)
- First posted
- 22 Dec 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pre/posttest randomized control trial design.
In this study all patients will be randomly assigned into two groups (30 in each group) :
- Group A will do baduanjin exercise in addition to traditional medical treatment.
- Group B will take traditional medical treatment only.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
- Model description
- Pre/posttest randomized control trial
| Arm | Type | Receives |
|---|---|---|
| Baduanjin exercise in addition to medical treatment | Experimental | Other: Baduanjin exercise30 patients with metabolic syndrome do baduanjin exercise in addition to traditional medical treatment |
| Traditional medical treatment | Experimental | Other: Baduanjin exercise30 patients with metabolic syndrome taking traditional medical treatment |
Who may qualify
- Ages
- 60 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- metabolic syndrome patients
Key exclusion criteria (4 listed)
- patients with Respiratory diseases
- patients with pacemaker patients
- patients with Neurological diseases
- patients with orthopedic diseases
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Baduanjin exerciseBaduanjin exercise | Other | Baduanjin exercise in addition to medical treatment, Traditional medical treatment |
Primary outcome
Fasting glucose level
Time frame: 3 months
Pre/post fasting glucose level in blood
Lipids profile
Time frame: 3 months
Pre/post HDL \& lDL levels in blood
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Dec 2023.
Related trials for Metabolic Syndrome
RecruitingObservational study
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
Fanconi Anemia, Inherited Bone Marrow Failure Syndrome
Not yet recruitingPhase 2
Osilodrostat for Glycemic Control in Mild Autonomous Cortisol Secretion (MACS) With Difficult-To-Control Type 2 Diabetes - A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
Mild Autonomous Cortisol Secretion (MACS), Diabetes Mellitus (Type 2)
Active, not recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
Not yet recruitingObservational study
Clinical Genetics Branch Eligibility Screening Survey
Melanoma, Li-Fraumeni Syndrome
Not yet recruitingPhase 2
Effects of Meal Macronutrients on Postprandial Lipids
Nephrotic Syndrome, Lipodystrophy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Baduanjin exercise in people with Metabolic Syndrome, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 22 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Ahmed Mohamed Eldeeb, Master (01153278847, eldeebahmed2018@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Fasting glucose level (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2023.